Intervention Review

Metformin monotherapy for type 2 diabetes mellitus

  1. Antonio Saenz1,*,
  2. Inmaculada Fernandez-Esteban2,
  3. Angel Mataix2,
  4. Monica Ausejo Segura3,
  5. Marta Roqué i Figuls4,
  6. David Moher5

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 30 SEP 2015

Assessed as up-to-date: 30 SEP 2003

DOI: 10.1002/14651858.CD002966.pub4

How to Cite

Saenz A, Fernandez-Esteban I, Mataix A, Ausejo Segura M, Roqué i Figuls M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD002966. DOI: 10.1002/14651858.CD002966.pub4.

Author Information

  1. 1

    INSALUD - Madrid, Centro de Salud Pozuelo 1, Pozuelo de Alarcón, Madrid, Spain

  2. 2

    Instituto Madrileño de la Salud, Area 11, Madrid, Madrid, Spain

  3. 3

    Servicio de Farmacia Atencion Frimaria, Madrid, Spain

  4. 4

    CIBER Epidemiología y Salud Pública (CIBERESP), Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Catalunya, Spain

  5. 5

    Ottawa Hospital Research Institute, Ottawa, ON, Canada

*Antonio Saenz, Centro de Salud Pozuelo 1, INSALUD - Madrid, Emisora s/n, Pozuelo de Alarcón, Madrid, 28224, Spain.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 30 SEP 2015


Reason for Withdrawal

Since the last publication of this review multiple changes like new publications, methods and other standards make it necessary to withdraw this review and register a new title on the same topic. To view the published versions of this article, please click the 'Other versions' tab.